SB-649,915 is a serotonin reuptake inhibitor and 5-HT1A and 5-HT1B receptor antagonist which is being investigated for its antidepressant effects. Relative to the selective serotonin reuptake inhibitors (SSRIs), SB-649,915 has a faster onset of action and may also have greater clinical efficacy as well. This can be attributed to blockade of 5-HT1A and 5-HT1B autoreceptors which inhibit serotonin release.

CAS：420785-70-2
中文别名：
英文别名：6-[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-ylimino)-methyl]-2,3-dimethoxy-benzoic acid ethyl ester;ETHYL 6-[(1,5-DIMETHYL-3-OXO-2-PHENYL-PYRAZOL-4-YL)IMINOMETHYL]-2,3-DIMETHOXY-BENZOATE;Benzoic acid,6-(((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)imino)methyl)-2,3-dimethoxy-,ethyl ester;6-[(1-{2-[(2-methyl-5-quinolinyl)oxy]ethyl}-4-piperidinyl)methyl]-2H-1,4-benzoxazin-3(4H)-one;
分子式：C26H29N3O3
分子量：431.527
精确质量：431.221
Psa：67.18
Logp：4.2306